Valeant Shares Surge

Valeant Shares Surge


Valeant Pharmaceuticals International Inc. said it's making progress selling assets and is bringing in more cash, helping chip away at its debt and allowing it to boost its full-year forecast. The forecast increase is a welcome sign for investors amid declining sales, legal troubles and a still-high debt burden, and the drugmaker's stock gained 16 percent to $11.23 at 8:29 a.m. in New York.



from Biotech News